Watkinsville, GA, United States of America

Teshome Mebatsion

USPTO Granted Patents = 20 (Patent Applications = 5)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 23)

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

Boehringer Ingelheim Animal Health USA Inc.

patents

1 out of 842

University of Georgia Research Foundation, Inc.

patents

4. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12385068 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2025-08-12),

2. 12280106 - Modified Marek's disease virus, and vaccines made therefrom (2025-04-21),

3. 11510978 - Modified Marek's disease virus, and vaccines made therefrom (2022-11-29),

4. 11421249 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2022-08-23),

5. 11058761 - Recombinant vectors expressing antigens of avian influenza virus and uses thereof (2021-07-13),

6. 11033616 - Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom (2021-06-15),

7. 10822620 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2020-11-03),

8. 10751407 - PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof (2020-08-25),

9. 10548967 - Attenuated swine influenza vaccines and methods of making and use thereof (2020-02-04),

10. 10350287 - Hendra virus recombinant compositions and uses thereof (2019-07-16),

11. 10323257 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2019-06-18),

12. 10010605 - FMDV recombinant vaccines and uses thereof (2018-07-03),

13. 10006050 - Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom (2018-06-26),

14. 9981033 - PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof (2018-05-29),

15. 9770502 - Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof (2017-09-26),

Title: Innovations by Teshome Mebatsion: Advancements in Avian Vaccines

Introduction

Teshome Mebatsion, an accomplished inventor based in Watkinsville, GA, has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for avian diseases. With a total of 18 patents to his name, Mebatsion has demonstrated a remarkable commitment to innovation and improving the health of poultry.

Latest Patents

Among his latest patents, Mebatsion has developed a vaccine for Marek's disease that utilizes a modified strain of the Marek's Disease Virus (MDV), specifically strain CVI988. This innovative vaccine employs a recombinant viral agent that has been transformed with foreign DNA, including a sequence from a reticuloendotheliosis virus. It offers a safe and effective immunization option for chickens, eliciting a strong immune response without significant pathogenicity.

Additionally, Mebatsion has worked on recombinant herpesvirus of turkeys (HVT) vectors that express multiple antigens from various avian pathogens. This invention not only enables better vaccination strategies against multiple diseases but also supports the development of polyvalent vaccines that can improve poultry health and productivity.

Career Highlights

Mebatsion has had a fruitful career, working with reputable companies such as Merial Limited and Boehringer Ingelheim Animal Health USA Inc. His roles at these organizations have allowed him to leverage his expertise in vaccine development and contribute to groundbreaking innovations in the field.

Collaborations

Throughout his career, Mebatsion has collaborated with notable individuals in the industry, including Joyce Pritchard and Michel Joseph Bublot. These partnerships have played an essential role in fostering innovation and sharing knowledge aimed at advancing avian health.

Conclusion

Teshome Mebatsion's contributions to veterinary medicine, particularly through his innovative patents, highlight the importance of continuous research and development in the field of avian health. His commitment to improving vaccine efficacy and safety will undoubtedly have a lasting impact on poultry industries, promoting both animal welfare and agricultural productivity.

This text is generated by artificial intelligence and may not be accurate.